Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale

BACKGROUND: Although oxaliplatin is widely established as a standard treatment in colorectal cancer (CRC), oxaliplatin-induced neuropathy has emerged as a prominent dose-limiting side effect associated with quality of life decrements. Ongoing monitoring and management of neuropathy is important for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Karen, Lyleroehr, Madison, Shaunfield, Sara, Lacson, Leilani, Corona, Maria, Kircher, Sheetal, Nittve, Malin, Cella, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031152/
https://www.ncbi.nlm.nih.gov/pubmed/32104551
http://dx.doi.org/10.4251/wjgo.v12.i2.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031152/
https://www.ncbi.nlm.nih.gov/pubmed/32104551
http://dx.doi.org/10.4251/wjgo.v12.i2.205

Ejemplares similares